Position in CGEN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$53,393
+$15,692 QoQ
Shares Held
24,950
+41.0% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 82 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Janney Montgomery Scott LLC holds $121,989,266 across 55 Biotechnology names. CGEN ranks #53 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
85,735 | $42,587,146 | |
| 2 | SPRY |
ARS Pharmaceuticals, Inc.
|
2,064,498 | $16,536,628 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,176 | $7,592,223 | |
| 4 | INCY |
Incyte Corp
|
52,727 | $5,977,132 | |
| 5 | EXEL |
Exelixis, Inc.
|
89,664 | $4,878,618 | |
| 6 | ZVRA |
Zevra Therapeutics, Inc.
|
272,194 | $3,903,261 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
13,087 | $3,203,304 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
79,550 | $2,815,274 |
All Filings in CGEN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,393 | 24,950 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $37,701 | 17,700 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $26,316 | 17,200 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $39,984 | 27,200 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $50,196 | 28,200 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $42,632 | 29,200 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $38,173 | 24,950 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $45,702 | 25,250 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $41,916 | 24,950 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $64,371 | 24,950 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $42,966 | 21,700 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $12,741 | 13,700 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $14,478 | 12,700 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $8,890 | 12,700 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $9,144 | 12,700 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $9,273 | 14,050 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $26,177 | 14,150 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $45,563 | 14,150 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $90,945 | 21,150 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $296,129 | 49,603 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $468,672 | 56,603 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $503,399 | 58,603 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $682,798 | 56,383 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $882,375 | 54,300 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $714,952 | 47,600 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $303,468 | 41,800 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||